This memorandum provides supplemental guidance on the provision of care for individuals diagnosed with gender dysphoria (GD) within the Military Health System's direct care component and through the Supplemental Health Care Program.

Establishes a collaborative process between the Military Services and the Defense Health Agency for providing transparent information on the assignment and availability of uniformed medical and dental personnel, civilian employee, and contractor personnel to support health care delivery in military medical treatment facilities and dental treatment ...

Details the guiding principles, responsibilities, and processes for conducting Human Capital Distribution in the Military Health System.

Establishes a collaborative process between the Military Services and the Defense Health Agency for notifying the Director, DHA of changes in availability of Active Component uniformed medical and dental personnel on orders to military medical treatment facilities and military dental treatment facilities.

Establishes policy, assigns responsibilities, and provides procedures for planning and programming the uniformed medical and dental workforce within military medical treatment facilities and dental treatment facilities.

This memorandum distributes the DoD WBH Research Strategy which provides guidance for the DoD research and development activities to coordinate, optimize, and advance warfighter brain health science.

DOD components will take necessary actions to ensure JYNNEOS replaces ACAM2000 as the primary pre-event smallpox vaccine for use in at-risk DOD service members, members of the DOD expeditionary workforce, select laboratory workers, and first responders.

This policy memorandum establishes the 2024 premium rates for TRICARE Reserve Select, TRICARE Retired Reserve, TRICARE Young Adult, and the Continued Health Care Benefit Program.

This memorandum notifies DHA directors and staff about the Notification and Federal Employee Antidiscrimination and Retaliation Act Policy.